Kalsiyum asetat etkileşimleri

Avoid the use of calcium supplements, including calcium-based nonprescription antacids, concurrently with calcium acetate capsules. (Kalsiyum asetat etiketi, Uyarılar ve önlemler)

Calcium carbonate, aluminum hydroxide, magnesium hydroxide Prevention or Management: Phenytoin and antacids should not be taken at the same time of day Antineoplastic agents (usually in combination) Bleomycin, carboplatin, cisplatin, doxorubicin, methotrexate Antiviral agents Fosamprenavir, nelfinavir, ritonavir Antiepileptic drugs Carbamazepine, vigabatrin Other… (Fenitoin etiketi, İlaç etkileşimleri)

Calcium Supplements Uncontrolled intake of additional calcium-containing preparations should be avoided (see PRECAUTIONS: General ). (Kalsitriol etiketi, İlaç etkileşimleri)

Avoid the use of calcium supplements, including calcium-based nonprescription antacids, concurrently with calcium acetate capsules. (Kalsiyum asetat etiketi, Uyarılar ve önlemler)

If blockage occurs, calcium salts may reverse these phenomena but mechanical respiratory assistance may be necessary. (Neomisin etiketi, Kutulu uyarı)

Avoid the use of calcium supplements, including calcium-based nonprescription antacids, concurrently with calcium acetate capsules. (Kalsiyum asetat etiketi, Uyarılar ve önlemler)

Do not administer simultaneously with calcium-containing IV solutions. (Seftriakson etiketi, Uyarılar ve önlemler)

Avoid the use of calcium supplements, including calcium-based nonprescription antacids, concurrently with calcium acetate capsules. (Kalsiyum asetat etiketi, Uyarılar ve önlemler)

• If treatment with a gastric acid reducing agent is required, consider using a H2‑receptor antagonist (e.g., ranitidine or famotidine) or an antacid (e.g., calcium carbonate). (Akalabrutinib etiketi, İlaç etkileşimleri)

Calcium acetate capsules may decrease the bioavailability of tetracyclines or fluoroquinolones via this mechanism. (Kalsiyum asetat etiketi, İlaç etkileşimleri)

WARNINGS AND PRECAUTIONS Treat mild hypercalcemia by reducing or interrupting calcium acetate capsules and Vitamin D. (Kalsiyum asetat etiketi, Uyarılar ve önlemler)

Calcium acetate capsules may decrease the bioavailability of tetracyclines or fluoroquinolones via this mechanism. (Kalsiyum asetat etiketi, İlaç etkileşimleri)

Hypercalcemia may aggravate digitalis toxicity. (Kalsiyum asetat etiketi, Uyarılar ve önlemler)

WARNINGS AND PRECAUTIONS Treat mild hypercalcemia by reducing or interrupting calcium acetate capsules and Vitamin D. (Kalsiyum asetat etiketi, Uyarılar ve önlemler)

Calcium acetate capsules may decrease the bioavailability of tetracyclines or fluoroquinolones via this mechanism. (Kalsiyum asetat etiketi, İlaç etkileşimleri)

…Interactions Concomitant Drug Class: Drug Name Effect on Concentration Increase = ↑; Decrease = ↓; No Effect = ↔ Clinical Comment Antacids: antacids (e.g., aluminum, magnesium hydroxide, or calcium carbonate) ↔ RPV (antacids taken at least 2 hours before or at least 4 hours after RPV) ↓ RPV (concomitant intake) Administer antacids at least 2 hours before or at least 4… (Emtrisitabin, rilpivirin ve tenofovir etiketi, İlaç etkileşimleri)

Instruct patients to take supplemental calcium and vitamin D if their dietary intake is inadequate (see Dosage and Administration [2.3] ) . (İbandronat etiketi, Uyarılar ve önlemler)

WARNINGS AND PRECAUTIONS Treat mild hypercalcemia by reducing or interrupting calcium acetate capsules and Vitamin D. (Kalsiyum asetat etiketi, Uyarılar ve önlemler)

Calcium acetate capsules may decrease the bioavailability of tetracyclines or fluoroquinolones via this mechanism. (Kalsiyum asetat etiketi, İlaç etkileşimleri)

See FPI for drugs that may interfere with systemic exposure and reduce mycophenolate mofetil efficacy: antacids with magnesium or aluminum hydroxide, proton pump inhibitors, drugs that interfere with enterohepatic recirculation, telmisartan, calcium-free phosphate binders. (Mikofenolat etiketi, İlaç etkileşimleri)

Calcium acetate capsules may decrease the bioavailability of tetracyclines or fluoroquinolones via this mechanism. (Kalsiyum asetat etiketi, İlaç etkileşimleri)

Calcium acetate capsules may decrease the bioavailability of tetracyclines or fluoroquinolones via this mechanism. (Kalsiyum asetat etiketi, İlaç etkileşimleri)

Calcium acetate capsules may decrease the bioavailability of tetracyclines or fluoroquinolones via this mechanism. (Kalsiyum asetat etiketi, İlaç etkileşimleri)

WARNINGS AND PRECAUTIONS Treat mild hypercalcemia by reducing or interrupting calcium acetate capsules and Vitamin D. (Kalsiyum asetat etiketi, Uyarılar ve önlemler)

…Drug Name Effect on Concentration of Rilpivirine or Concomitant Drug Clinical Comment ↑=increase, ↓=decrease, ↔=no change Antacids: antacids (e.g., aluminum or magnesium hydroxide, calcium carbonate) ↔ rilpivirine (antacids taken at least 2 hours before or at least 4 hours after rilpivirine) The combination of EDURANT or EDURANT PED and antacids should be used… (Rilpivirin etiketi, İlaç etkileşimleri)

Calcium Supplements/Antacids When Risedronate sodium delayed-release was administered following breakfast, the co-administration of a tablet containing 600 mg of elemental calcium and 400 international units vitamin D reduced risedronate bioavailability by approximately 38% [ see Clinical Pharmacology (12.3) ] . (Risedronat etiketi, İlaç etkileşimleri)

If corrected serum calcium falls below the lower limit of normal or symptoms of hypocalcemia develop, start or increase calcium supplementation (including calcium, calcium-containing phosphate binders, and/or vitamin D sterols or increases in dialysate calcium concentration). (Sinakalset etiketi, Uyarılar ve önlemler)

Ciprofloxacin In a study of 15 healthy subjects, a co-administered single dose of 4 calcium acetate tablets approximately 2.7 g decreased the bioavailability of ciprofloxacin by approximately 50%. (Kalsiyum asetat etiketi, İlaç etkileşimleri)

Calcium acetate capsules may decrease the bioavailability of tetracyclines or fluoroquinolones via this mechanism. (Kalsiyum asetat etiketi, İlaç etkileşimleri)

Calcium acetate capsules may decrease the bioavailability of tetracyclines or fluoroquinolones via this mechanism. (Kalsiyum asetat etiketi, İlaç etkileşimleri)

Calcium supplements, antacids or oral medications containing multivalent cations interfere with absorption of alendronate. (Alendronat etiketi, İlaç etkileşimleri)

If neuromuscular blockade occurs, it may be reversed by the administration of calcium salts but mechanical respiratory assistance may be necessary. (Amikasin etiketi, Uyarılar ve önlemler)

If neuromuscular blockade occurs, calcium salts may reverse it. (Gentamisin etiketi, İlaç etkileşimleri)

Concomitant Drug Class: Drug Name Effect on Concentration Clinical Comment Antacids containing polyvalent cations (e.g., aluminum or magnesium hydroxide, calcium carbonate) ↓Cabotegravir Administer antacid products at least 2 hours before or 4 hours after taking VOCABRIA. (Kabotegravir etiketi, İlaç etkileşimleri)

Calcinosis cutis can occur with or without extravasation of Calcium Gluconate Injection, is characterized by abnormal dermal deposits of calcium salts, and clinically manifests as papules, plaques, or nodules that may be associated with erythema, swelling, or induration. (Kalsiyum glukonat etiketi, Uyarılar ve önlemler)

Calcinosis cutis can occur with or without extravasation of Calcium Chloride Injection, is characterized by abnormal dermal deposits of calcium salts, and clinically manifests as papules, plaques, or nodules that may be associated with erythema, swelling, or induration. (Kalsiyum klorür etiketi, Uyarılar ve önlemler)

…Clinically Significant Drug Interaction with TAMIFLU No dose adjustments are needed for either oseltamivir or the concomitant drug when coadministering oseltamivir with amoxicillin, acetaminophen, aspirin, cimetidine, antacids (magnesium and aluminum hydroxides and calcium carbonates), rimantadine, amantadine, or warfarin [see Clinical Pharmacology (12.3) ] . (Oseltamivir etiketi, İlaç etkileşimleri)

Moreover, atazanavir, atazanavir/ritonavir, boceprevir, calcium carbonate antacids, darunavir/ritonavir, efavirenz, etravirine, omeprazole, or tipranavir/ritonavir did not have a clinically meaningful effect on the pharmacokinetics of raltegravir. (Raltegravir etiketi, İlaç etkileşimleri)